Lin Shen

18.8k citations
273 papers · 7.6k · 6 hit papers · h-index 40

Impact in

  • Oncology top 1%
    • Cancer Immunotherapy and Biomarkers
    • HER2/EGFR in Cancer Research
    • Gastrointestinal Tumor Research and Treatment

Papers in

    • Cancer Immunotherapy and Biomarkers 43
    • Colorectal Cancer Treatments and Studies 20
    • HER2/EGFR in Cancer Research 16
    • Pancreatic and Hepatic Oncology Research 15
    • Gastric Cancer Management and Outcomes 54
    • Lung Cancer Treatments and Mutations 21

Lin Shen

258 papers receiving 7.5k citations

Lin Shen's Hit Papers

Claudin 18.2 as a novel therapeutic target 2024 · 103 citations
1030+4+8Years since publication250500750

Peers

Lin Shen
Comparison fields: 5 of 160
  • Oncology 2.3k
  • Gastroenterology 390
  • Cancer Research 825
  • Pulmonary and Respiratory Medicine 1.7k
  • Hepatology 232
Replace Seung‐Mo Hong with:
Seung‐Mo Hong South Korea
Kenoki Ohuchida Japan
Song Cheol Kim South Korea
Hideki Ueno Japan
Zhenning Wang China
Guobin Wang China
Baorui Liu China
Tatsuya Oda Japan
Genevieve M. Boland United States
Andreas Gäumann Germany
Lin Shen relative to Seung‐Mo Hong South Korea Seung‐Mo Hong's profile →
Citations per field
00.5×2.8×
Seung‐Mo Hong · 1×
Citations per year

Countries citing papers authored by Lin Shen

Since Specialization
Citations

This map shows the geographic impact of Lin Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Shen more than expected).

Fields of papers citing papers by Lin Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lin Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Shen. The network helps show where Lin Shen may publish in the future.

Co-authors

The 25 scholars most cited alongside Lin Shen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lin Shen Line = papers co-authored together Lin Shen links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 273 papers — load more, or switch the sort, to bring in the rest.

#Work
1
3D printing of conducting polymers
Hit paper breakdown →
2020854
2
The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer
Hit paper breakdown →
2021473
3
Management of gastric cancer in Asia: resource-stratified guidelines
Hit paper breakdown →
2013389
4 2008305
5
Pembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma: interim analyses from the phase 3 KEYNOTE-811 randomised placebo-controlled trial
Hit paper breakdown →
2023246
6 2017227
7 2019220
8
The loss of RNA N6-adenosine methyltransferase Mettl14 in tumor-associated macrophages promotes CD8+ T cell dysfunction and tumor growth
Hit paper breakdown →
2021213
9 2011131
10 2022128
11 2015110
12 2022105
13
Claudin 18.2 as a novel therapeutic target
Hit paper breakdown →
2024103
14 201696
15 201891
16 201886
17 201486
18 202084
19 202179
20 201776

About Lin Shen

Lin Shen is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Molecular Biology and Radiology, Nuclear Medicine and Imaging, having authored 273 papers that have together received 7.6k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (54 papers), Cancer Immunotherapy and Biomarkers (43 papers), Esophageal Cancer Research and Treatment (31 papers), Lung Cancer Treatments and Mutations (21 papers), Colorectal Cancer Treatments and Studies (20 papers), HER2/EGFR in Cancer Research (16 papers), Pancreatic and Hepatic Oncology Research (15 papers) and Cancer Genomics and Diagnostics (14 papers). The work is most often cited by research in Oncology (2.3k citations), Gastroenterology (390 citations), Cancer Research (825 citations), Pulmonary and Respiratory Medicine (1.7k citations) and Hepatology (232 citations). Lin Shen has collaborated with scholars based in China, Ethiopia and United States. Frequent co-authors include Jingkun Xu, Baoyang Lu, Xuanhe Zhao, Kai Qu, Hyunwoo Yuk, Jianhong Luo, Jifang Gong, Jing Gao, Zhi Peng and Cheng Zhang. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Journal for ImmunoTherapy of Cancer, Frontiers in Oncology and Cancer Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact